Psychodermatology: An update

Journal of the American Academy of Dermatology

Volumn 34, Issue 6, 1996, Pages 1030-1046

  Gupta, Madhulika A ^a,c   Gupta, Aditya K ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ANXIETY NEUROSIS; DEPRESSION; DERMATOLOGY; DISEASE ASSOCIATION; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOSIS; PSYCHOSOMATICS; PSYCHOTHERAPY; REVIEW; SKIN DISEASE; SKIN MANIFESTATION;

EID: 0029892758     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90284-4     Document Type: Review

References (196)

1. Medansky RS, Handler RM. Dermatopsychosomatics: classification, physiology, and therapeutic approaches. J Am Acad Dermatol 1981;5:125-36.
2. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983;119:501-12.
3. Koo JYM, Pham CT. Psychodermatology: practical guidelines on pharmacotherapy. Arch Dermatol 1992; 126:381-8.
4. Whitlock FA. Psychophysiological aspects of skin disease. In: Rook A, editor. Major problems in dermatology. London: WB Saunders, 1976:110-210.
5. Obermayer ME. Psychocutaneous medicine. Springfield, Ill: Charles C Thomas, 1955:175-304.
6. Panconesi P. Psychosomatic dermatology. Clin Dermatol 1984;2:94-179.
7. Folks DG, Kinney FC. The role of psychological factors in dermatologic conditions. Psychosomatics 1992;33:45-54.
8. Gupta MA. Dermatology. In: Stoudemire A, Fogel BS, editors. Psychiatric care of the medical patient. New York: Oxford University Press, 1993:681-90.
9. Van Moffaert M. Psychodermatology: an overview. Psychother Psychosom 1992;58:125-36.
10. Savin JA, Cotterill JA. Psychocutaneous disorders. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. Oxford: Blackwell Scientific Publications, 1992:2479-96.
11. Rudzki E, Borkowski W, Czubalski K. The suggestive effect of placebo on the intensity of chronic urticaria. Acta Allergol 1970;25:70-3.
12. Christian GL, Krueger GG. Clindamycin vs. placebo as adjunctive therapy in moderately severe acne. Arch Dermatol 1975;111:997-1000.
13. Gupta MA, Gupta AK, Haberman HF. Psychotropic drugs in dermatology. J Am Acad Dermatol 1986; 14:633-45.
14. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
15. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis. Arch Dermatol 1978;114:940-3.
16. Cotterill JA. Dermatologic non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol 1981;104:611-9.
17. Hay GG. Dysmorphophobia. Br J Psychiatry 1970; 116:399-406.
18. Eckert J. Diffuse hair loss and psychiatric disturbance. Acta Derm Venereol (Stockh) 1975;55:147-9.
19. Gupta MA, Gupta AK, Haberman HF. The self-inflicted dermatoses: a critical review. Gen Hosp Psychiatry 1987;9:45-52.
20. Fabisch W. Psychiatric aspects of dermatitis artefacta. Br J Dermatol 1980;102:29-34.
21. Spraker MK. Cutaneous artifactual disease: an appeal for help. Pediatr Clin North Am 1983;30:659-68.
22. Shelley WB. Dermatitis artefacta induced in a patient by one of her multiple personalities. Br J Dermatol 1981; 105:587-9.
23. Gupta MA, Gupta AK. Dermatitis artefacta and sexual abuse. Int J Dermatol 1993;32:825-6.
24. Jones DPH. Dermatitis artefacta in mother and baby as child abuse. Br J Psychiatry 1983;143:199-200.
25. Stein DJ, Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. J Am Acad Dermatol 1992;26:237-42.
26. Freunsgaard K. Neurotic excoriations: a controlled psychiatric examination. Acta Psychiatr Scand 1984;69(suppl):1-52.
27. Gupta MA, Gupta AK, Haberman HF. Neurotic excoriations: a review and some new perspectives. Compr Psychiatry 1986;27:381-6.
28. Gupta MA, Gupta AK. Fluoxetine is an effective treatment for neurotic excoriations: a case report. Cutis 1993; 51:386-7.
29. Seitz PFD. Psychocutaneous aspects of persistent pruritus and excessive excoriation. Arch Dermatol Syph 1951; 64:136-41.
30. Waisman M. Pickers, pluckers, and imposters: a panorama of cutaneous self-mutilation. Postgrad Med 1965; 38:620-30.
31. Cormia FE. Basic concepts in the production and management of the psychosomatic dermatoses I. Br J Dermatol 1951;63:83-92.
32. Pusey WA, Senear FE. Neurotic excoriations with report of cases. Arch Dermatol Syphilol 1920;1:270-8.
33. Kenta A, Drummond LM. Acne excoriee: a case report of treatment using habit reversal. Clin Exp Dermatol 1989; 14:163-4.
34. Sneddon J, Sneddon I. Acne excoriée: a protective device. Clin Exp Dermatol 1983;8:65-8.
35. Koo JYM, Smith LL. Psychologic aspects of acne. Pediatr Dermatol 1991;8:185-8.
36. Gupta MA, Gupta AK, Schork NJ. Psychosomatic factors affecting self-excoriative behavior among women with mild to moderate facial acne vulgaris. Psychosomatics (in press)
37. Gupta MA, Gupta AK, Haberman HF. Dermatologic signs in anorexia nervosa and bulimia nervosa. Arch Dermatol 1987;123:1386-90.
38. Swedo SE, Rapoport JL. Annotation: trichotillomania. J Child Psychol Psychiatry 1991;32:401-9.
39. Swedo SE, Leonard HL, Rapoport JL, et al. A doublebund comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;321:497-501.
40. Muller SA, Winkelmann RK. Trichotillomania: a clinicopathologic study of 24 cases. Arch Dermatol 1972; 105:535-40.
41. Christenson GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 1991;148:365-70.
42. Greenberg R, Sarner CA. Trichotillomania: symptom and syndrome. Arch Gen Psychiatry 1965;12:482-9.
43. Sanderson KV, Hall-Smith P. Tonsure trichotillomania. Br J Dermatol 1970;82:343-50.
44. Krishnan RRK, Davidson JRT, Guajardo C. Trichotillomania: a review. Compr Psychiatry 1985;26:123-8.
45. Oguchi T, Miura S. Trichotillomania: its psychopathological aspect. Compr Psychiatry 1977;18:177-82.
46. Ilana E, Baht R, Littner MM, et al. Detection of psychopathologic trends in glossodynia patients. Psychosom Med 1994;56:389-94.
47. Lamey P-J, Lamb AB. Prospective study of etiological factors in burning mouth syndrome. Br Med J 1988; 296:1243-6.
48. Rojo L, Silvestre F, Bagan JV, et al. Psychiatric morbidity in burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1993;75:308-11.
49. Gorsky M, Silverman SJR, Chinn H. Burning mouth syndrome: a review of 98 cases. J Oral Med 1987;42:7-9.
50. Hampf G, Vikkula J, Ylipaavalniemi P, et al. Psychiatric disorders in orofacial dysaesthesia. Int J Oral Maxillofac Surg 1987;16:402-7.
51. Fried RG. Evaluation and treatment of "psychogenic" pruritus and self-excoriation. J Am Acad Dermatol 1994;30:993-9.
52. Ratnoff OD. The psychogenic purpuras: a review of autoerythrocyte sensitization, autosensitization to DNA, "hysterical" and factitial bleeding, and the religious stigmata. Semin Hematol 1980;17:192-213.
53. Ratnoff OD. Psychogenic purpura (autoerythrocyte sensitization): an unsolved dilemma. Am J Med 1989;87:3-16N to 3-21N.
54. Koblenzer CS. Psychocutaneous disease. In: Moschella SL, Hurley HJ, editors. Dermatology. Philadelphia: WB Saunders, 1992:2025-41.
55. Faulstich ME, Williamson DA. An overview of atopic dermatitis: toward a bio-behavioral integration. J Psychosom Res 1985;29:415-7.
56. Gil KM, Keefe FJ, Sampson HA, et al. The relation of stress and family environment to atopic dermatitis symptoms in children. J Psychosom Res 1987;31:673-84.
57. King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991;35:697-706.
58. Al-Ahmar HF, Kurban AK. Psychological profile of patients with atopic dermatitis. Br J Dermatol 1976;95:373-7.
59. White A, Horne DJ, Varigos GA. Psychological profile of the atopic eczema patient. Australas J Dermatol 1990; 31:13-6.
60. Ginsburg IH, Prystowsky JH, Kornfeld DS, et al. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993;32:656-60.
61. Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993;37:637-42.
62. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40.
63. Ullman KC, Moore RW, Reidy M. Atopic eczema: a clinical psychiatric study. J Asthma Res 1977;14:91-9.
64. Koblenzer CS, Koblenzer PJ. Chronic intractable atopic eczema. Arch Dermatol 1988;124:1673-7.
65. Allen AD. Intractable atopic eczema suggests major affective disorder: poor parenting is secondary [Letter]. Arch Dermatol 1989;125:567-8.
66. Seville RH. Psoriasis and stress. Br J Dermatol 1977; 97:297-302.
67. Polenghi MM, Molinari E, Gala C, et al. Experience with psoriasis in a psychosomatic dermatology clinic. Acta Derm Venereol (Stockh) 1994;186:65-6.
68. Nyfors A, Lemholt K. Psoriasis in children. Br J Dermatol 1975;92:437-42.
69. Al' Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
70. Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol (Stockh) 1994;186:62-4.
71. Gupta MA, Gupta AK, Kirkby S, et al. A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 127 patients. Gen Hosp Psychiatry 1989;11:166-73.
72. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989;20:53-63.
73. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118:195-201.
74. Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen Hosp Psychiatry 1987;9:157-66.
75. Vidoni D, Campiutti E, D'Aronco R, et al. Psoriasis and alexithymia. Acta Derm Venereol (Stockh) 1989; 146:91-2.
76. Rubino IA, Sonnino A, Stefanto CM, et al. Separation-individuation, aggression, and alexithymia in psoriasis. Acta Derm Venereol (Stockh) 1989;146:87-90.
77. Goldsmith LA, Fisher M, Wacks J. Psychological characteristics of psoriatics. Arch Dermatol 1969;100:674-6.
78. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988;124:1052-7.
79. Morse RM, Perry HO, Hurt RD. Alcoholism and psoriasis. Alcohol Clin Exp Res 1985;9:396-9.
80. Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993;28:730-2.
81. Michaelsson G. Chronic urticaria. Acta Derm Venereol (Stockh) 1969;49:404-16.
82. Stewart JH, Goodman MM. Earthquake urticaria. Cutis 1989;43:340.
83. Rees L. An aetiological study of chronic urticaria and angioneurotic oedema. J Psychosom Res 1957;2:172-89.
84. Czubalski K, Rudzki E. Neuropsychic factors in physical urticaria. Dermatologica 1977;154:1-4.
85. Graham DT, Wolf S. Pathogenesis of urticaria: experimental study of life situations, emotions, and cutaneous vascular reactions. JAMA 1950;143:1396-402.
86. Monroe EW, Jones HE. Urticaria: an updated review. Arch Dermatol 1977;113:80-90.
87. Juhlin L. Recurrent urticaria: clinical investigations of 330 patients. Br J Dermatol 1981;104:369-81.
88. Wittkower ED. Studies of the personality of patients suffering from urticaria. Psychosom Med 1953;15:116-20.
89. Badoux A, Levy DA. Psychologic symptoms in asthma and chronic urticaria. Ann Allergy 1994;72:229-34.
90. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990;123:769-74.
91. Harvey NS, Mikhail WI. Seasonal hypomania in a patient with cold urticaria. Br J Psychiatry 1986;149:238-41.
92. Gupta MA, Gupta AK. Severe recurrent urticaria associated with panic disorder: A syndrome responsive to selective serotonin reuptake inhibitor (SSRI) antidepressants? Cutis 1995;56:53-4.
93. Anderson I. Alopecia areata: a clinical study. Br Med J 1950;2:1250-2.
94. Perini GI, Veller Fornasa C, Cipriani R, et al. Life events and alopecia areata. Psychother Psychosom 1984;41:48-52.
95. Reinhold M. Relationship of stress to the development of symptoms in alopecia areata and chronic urticaria. Br Med J 1960;1:846-9.
96. Van Der Steen P, Boezeman J, Duller P, et al. Can alopecia areata be triggered by emotional stress? an uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol (Stockh) 1992;72:279-80.
97. MacAlpine I. Is alopecia areata psychosomatic? a psychiatric study. Br J Dermatol 1958;70:117-31.
98. Sandok BA. Alopecia areata: an apparent relationship to psychic factors. Am J Psychiatry 1964;121:184-5.
99. Muller SA, Winkelmann RK. Alopecia areata: an evaluation of 736 patients. Arch Dermatol 1963;88:290-7.
100. Colon EA, Popkin MK, Callies AL, et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991;32:245-51.
101. Koo JYM, Shellow WVR, Hallman CP, et al. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994;33:849-50.
102. The United States Pharmacopeial Convention, Inc. Drug information for the health care professional. USP-DI; vol 1. 14th ed. Taunton, Mass: Rand McNally, 1994.
103. Drug facts and comparisons. 1994 ed. St Louis: Wolters Kluwer, 1994.
104. Physicians' desk reference. 48th ed. Montvale, NJ: Medical Economics Data Production, 1994.
105. Schatzberg AF, Cole JO. Manual of clinical psychopharmacology. 2nd ed. Washington, DC: American Psychiatric Press, 1991:31-226.
106. Kaplan HI, Sadock BJ. Pocket handbook of psychiatric drug treatment. Baltimore: Williams & Wilkins, 1993.
107. Edwards JG. Adverse effects of antianxiety drugs. Drugs 1981;22:495-514.
108. Srebrnik A, Hes JP, Brenner S. Adverse cutaneous reactions to psychotropic drugs. Acta Derm Venereol (Stockh) 1991;158:1-12.
109. Gupta MA, Gupta AK, Ellis CN. Antidepressant drugs in dermatology. Arch Dermatol 1987;123:647-52.
110. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51(suppl):9-12.
111. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in post-herpetic neuralgia. Neurology 1982; 32:671-3.
112. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
113. Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica 1985;170:190-3.
114. Greene SL, Reed CE, Schroeter AL. Double-blind cross-over study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985;12:669-75.
115. Neittaanmäki H, Myöhänen T, Fräki JE. Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin. J Am Acad Dermatol 1984;11:483-9.
116. Savin JA, Paterson WD, Adam K, et al. Effects of trimeprazine and trimipramine on nocturnal scratching in patients with atopic eczema. Arch Dermatol 1979;115: 313-5.
117. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613-6.
118. Gelenberg AJ. Interactions: new antidepressants, nonsedating antihistamines and others. Biological Therapies in Psychiatry Newsletter 1995;18(5):17.
119. Gupta MA, Voorhees JJ. Psychosomatic dermatology: Is it relevant? Arch Dermatol 1990;126:90-3.
120. Koblenzer CS. Psychologic aspects of skin disease. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993:14-26.
121. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry 1980;137:535-44.
122. Kaplan HI, Sadock BJ. Typical signs and symptoms of psychiatric illness. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. Baltimore: Williams & Wilkins, 1989:468-75.
123. Hatch ML, Paradis C, Freidman S, et al. Obsessive-compulsive disorder in patients with chronic pruritic conditions: case studies and discussion. J Am Acad Dermatol 1992;26:549-51.
124. Kreuger DW. Body self and psychological self. New York: Brunner/Mazel, 1989:3-31.
125. Gupta MA, Schork NJ. Touch deprivation has an adverse effect on body image: some preliminary observations. Int J Eat Disord 1995;17:185-9.
126. Koblenzer CS. The dysmorphic syndrome. Arch Dermatol 1985;121:780-4.
127. Jowett S, Ryan T. Skin diseases and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-9.
128. Gupta MA, Gupta AK, Voorhees JJ. Starvation-associated pruritus: a clinical feature of eating disorders. J Am Acad Dermatol 1992;27:118-20.
129. White KP, Rothe MJ, Milanese A, et al. Perniosis in association with anorexia nervosa. Pediatr Dermatol 1994; 11:1-5.
130. Andersen AE. Drenching nocturnal sweats during weight recovery in eating disordered patients: a new syndrome. Presented at the Sixth International Conference on Eating Disorders. New York: April 29 to May 1, 1994.
131. Agris J, Simmons CW. Factitious (self-inflicted) skin wounds. Plast Reconstr Surg 1978;62:686-92.
132. Hollender MH, Abram HS. Dermatitis factitia. South Med J 1973;66:1279-85.
133. Halprin KM. The art of self-mutilation. III. Factitial dermatitis or dermatitis artefacta? JAMA 1967;199:119.
134. Lyell A. Dermatitis artefacta and self-inflicted disease. Scott Med J 1972;17:187-96.
135. Sneddon I, Sneddon J. Self-inflicted injury: a follow-up of 43 patients. Br Med J 1975;1:527-30.
136. Krupp NE. Self-caused skin ulcers. Psychosomatics 1977;18:15-9.
137. Van Dijk E, Van Voorst Vader PC. Dermatillomania. Dermatologica 1979;158:65-71.
138. Levy SW. A psychosomatic approach to the management of recalcitrant dermatoses. Psychosomatics 1963;4:334-7.
139. Fisher BK, Pearce KI. Neurotic excoriations: a personality evaluation. Cutis 1974;14:251-4.
140. Duke EE. Clinical experience with pimozide: emphasis on its use in postherpetic neuralgia. J Am Acad Dermatol 1983;8:845-50.
141. Swedo SE, Leonard HL. Trichotillomania: An obsessive compulsive spectrum disorder? Psychiatr Clin North Am 1992;15:777-90.
142. Muller SA. Trichotillomania. Dermatol Clin 1987;5:595-601.
143. Stanley MA, Swann AC, Bowers TC, et al. A comparison of clinical features in trichotillomania and obsessive-compulsive disorder. Behav Res Ther 1992;30:39-44.
144. Reeve EA, Bernstein GA, Christenson GA. Clinical characteristics and psychiatric comorbidity in children with trichotillomania. J Am Acad Child Adolesc Psychiatry 1992;31:132-8.
145. Swedo SE, Rapoport JL, Leonard HL, et al. Regional cerebral glucose metabolism of women with trichotillomania. Arch Gen Psychiatry 1991;48:828-33.
146. Anand P, Springall DR, Blank MA, et al. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991;124:547-9.
147. Gianetti A, Girolomoni G. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989;121:681-8.
148. Pincelli C, Fantini F, Massimi P, et al. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990;122:745-50.
149. Hampf BG, Malmstrom MJ, Aalberg VA, et al. Psychiatric disturbance in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1987;63:429-32.
150. Allen CM, Beck FM, Rossie KM, et al. Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986;61:44-6.
151. Kalivas L, Penick E, Kalivas J. Personality factors as predictors of therapeutic response to cryosurgery in patients with warts. J Am Acad Dermatol 1989;20:429-32.
152. Spanos NP, Williams V, Gwynn MI. Effects of hypnotic, placebo, and salicylic acid treatments on wart regression. Psychosom Med 1990;52:109-14.
153. Higgins EM, Du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull 1994;50:85-98.
154. Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993;69:670-6.
155. Jordan JM, Whitlock JA. Atopic dermatitis, anxiety, and conditioned scratch responses. J Psychosom Res 1974;18:297-9.
156. Arnetz BB, Fjellner B, Eneroth P, et al. Endocrine and dermatological concomitants of mental stress. Acta Derm Venereol (Stockh) 1991;156:9-12.
157. Faulstich ME, Williamson DA, Duchmann EG, et al. Psychophysiological analysis of atopic dermatitis. J Psychosom Res 1985;29:415-7.
158. Koehler T, Weber D. Psychophysiological reactions of patients with atopic dermatitis. J Psychosom Res 1992; 36:391-4.
159. Williams D. Management of atopic dermatitis in children: control of the maternal rejection factor. Arch Dermatol Syphilol 1951;63:545-7.
160. Brown D, Bettley F. Psychiatric treatment of eczema: a controlled trial. Br Med J 1971;2:729-34.
161. Haynes SN, Wilson CC, Jaffe PG, et al. Biofeedback treatment of atopic dermatitis: controlled case studies of eight cases. Biofeedback Self Regul 1979;4:195-209.
162. Horne DJ, White AE, Varigos GA. A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 1989;62:241-8.
163. Cole WC, Roth HL, Sachs LB. Group psychotherapy as an aid in the medical treatment of eczema. J Am Acad Dermatol 1988;18:286-91.
164. Cotterill JA. Psychophysiological aspects of eczema. Semin Dermatol 1990;9:216-9.
165. Melin L, Frederiksen T, Noren T, et al. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467-74.
166. Miller RM, Coger RW. Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol 1979; 101:435-40.
167. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
168. Fried RG, Friedman S, Paradis C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-5.
169. Arnetz BB, Fjellner B, Eneroth P, et al. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985;47:528-41.
170. Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438-42.
171. Pincelli C, Fantini F, Magnoni C, et al. Psoriasis and the nervous system. Acta Derm Venereol (Stockh) 1994; 186:60-1.
172. Eedy DJ, Johnston CF, Shaw C, et al. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 1991;96:434-8.
173. Farber EM, Nickoloff BJ, Recht B, et al. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986;14:305-11.
174. Deandrea D, Walker L, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review. J Clin Psychopharmacol 1982;2:119-204.
175. Sarantidis D, Waters D. A review and control study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983;143:42-50.
176. Selmanowitz VJ. Lithium, leukocytes, and lesions. Clin Dermatol 1986;4:170-5.
177. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979;115:1185-7.
178. Gupta MA, Schork NJ, Gupta AK, et al. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-90.
179. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol (Stockh) 1995;75:240-3.
180. Abel E, Moore US, Glathe JP. Psoriasis patient support group and self-care efficacy as an adjunct to day care center treatment. Int J Dermatol 1990;29:640-3.
181. Gaston L, Crombez JC, Lassonde M, et al. Psychological Stress and psoriasis: experimental and prospective correlations studies. Acta Derm Venereol (Stockh) 1991; 156:37-43.
182. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus associated with nocturnal wakenings: Organic or psychogenic? J Am Acad Dermatol 1989;21:479-84.
183. Pavlidakey GP, Hashimoto K, Heller GL, et al. Chlorpromazine-induced lupus-like disease. J Am Acad Dermatol 1985;13:109-15.
184. Kochevar IE. Possible mechanisms of toxicity due to photochemical products of protriptyline. Toxicol Appl Pharmacol 1980;54:258-64.
185. Champion RH, Roberts SO, Carpenter RG, et al. Urticaria and angio-oedema: a review of 554 patients. Br J Dermatol 1969;81:588-97.
186. Haustein UF. Adrenergic urticaria and adrenergic pruritus. Acta Derm Venereol (Stockh) 1990;70:82-4.
187. Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet 1985;2:1031-3.
188. Arnold HL, Odom KB, James WD. Diseases of the skin. 8th ed. Philadelphia: WB Saunders, 1990:131-58.
189. Sunder TR, Balsam MJ, Vengrow MI. Neurological manifestations of angioedema. JAMA 1982;247:2005-7.
190. Richelson E. Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc 1983; 58:40-6.
191. Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 1987;123:913-6.
192. Black S. Inhibition of immediate type hypersensitivity response by direct suggestion under hypnosis. Br Med J 1963;1:925-9.
193. Sperber J, Shaw J, Bruce S. Psychological components and the role of adjunct interventions in chronic idiopathic urticaria. Psychother Psychosom 1989;51:135-41.
194. De Waard-Van Der Spek FB, Oranje AP, De Raeymaecker DM, et al. Juvenile versus maturity-onset alopecia areata: a comparative retrospective clinical study. Clin Exp Dermatol 1989;14:429-33.
195. Beard HO. Social and psychological implications of alopecia areata. J Am Acad Dermatol 1986;14:697-700.
196. Perini G, Zara M, Cipriani R, et al. Imipramine in alopecia areata: a double-blind, placebo-controlled study. Psychother Psychosom 1994;61:195-8.